SAC Capital Discloses 7.2% Stake In Orexigen Therapeutics (OREX)

by Benzinga Staff
January 31, 2011 4:14 PM | 6 seconds read |
SAC Capital Discloses 7.2% Stake In Orexigen Therapeutics OREX, according to a SEC 13G filing.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: News
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!